PARISI, SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.891
AS - Asia 2.807
EU - Europa 2.291
SA - Sud America 778
AF - Africa 729
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 42
AN - Antartide 1
Totale 15.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.497
SG - Singapore 923
BR - Brasile 522
HK - Hong Kong 492
CN - Cina 481
IT - Italia 445
DE - Germania 295
FI - Finlandia 221
VN - Vietnam 168
PL - Polonia 128
UA - Ucraina 124
FR - Francia 122
SE - Svezia 121
GB - Regno Unito 90
RU - Federazione Russa 84
NL - Olanda 80
AT - Austria 44
CA - Canada 43
MX - Messico 43
AR - Argentina 40
TR - Turchia 39
ES - Italia 38
KR - Corea 38
IE - Irlanda 37
IN - India 37
BE - Belgio 36
KH - Cambogia 33
IQ - Iraq 32
ZA - Sudafrica 32
PY - Paraguay 31
EC - Ecuador 29
JO - Giordania 29
MA - Marocco 29
BO - Bolivia 28
CO - Colombia 28
DO - Repubblica Dominicana 28
LY - Libia 28
PS - Palestinian Territory 28
EG - Egitto 26
ID - Indonesia 26
LB - Libano 25
BB - Barbados 24
CI - Costa d'Avorio 24
IL - Israele 24
NZ - Nuova Zelanda 24
UZ - Uzbekistan 24
CM - Camerun 23
CZ - Repubblica Ceca 23
NP - Nepal 23
SO - Somalia 23
AE - Emirati Arabi Uniti 22
AL - Albania 22
AU - Australia 22
BD - Bangladesh 22
KG - Kirghizistan 22
KZ - Kazakistan 22
PA - Panama 22
PE - Perù 22
RS - Serbia 22
XK - ???statistics.table.value.countryCode.XK??? 22
AO - Angola 21
CH - Svizzera 21
CL - Cile 21
GA - Gabon 21
GF - Guiana Francese 21
IR - Iran 21
JM - Giamaica 21
MD - Moldavia 21
ME - Montenegro 21
SN - Senegal 21
AM - Armenia 20
EE - Estonia 20
GH - Ghana 20
GT - Guatemala 20
MG - Madagascar 20
MN - Mongolia 20
SI - Slovenia 20
TJ - Tagikistan 20
BS - Bahamas 19
DK - Danimarca 19
DZ - Algeria 19
ET - Etiopia 19
HR - Croazia 19
ML - Mali 19
MR - Mauritania 19
PK - Pakistan 19
RW - Ruanda 19
TN - Tunisia 19
BG - Bulgaria 18
CR - Costa Rica 18
CW - ???statistics.table.value.countryCode.CW??? 18
GR - Grecia 18
LU - Lussemburgo 18
LV - Lettonia 18
NE - Niger 18
PH - Filippine 18
RE - Reunion 18
SK - Slovacchia (Repubblica Slovacca) 18
TW - Taiwan 18
VE - Venezuela 18
Totale 14.828
Salva come PNG Salva come JPEG
Città #
Fairfield 1.278
Woodbridge 825
Ashburn 723
Chandler 682
Houston 563
Singapore 556
Hong Kong 467
Ann Arbor 433
Seattle 424
Cambridge 415
Wilmington 413
Jacksonville 411
Boardman 210
Princeton 191
San Diego 162
Santa Clara 159
Beijing 129
Padova 110
Bytom 99
Munich 97
Roxbury 94
Medford 78
Los Angeles 74
Helsinki 71
Dong Ket 48
Nanjing 46
São Paulo 45
Des Moines 44
Turku 44
Ho Chi Minh City 41
New York 41
Hefei 37
Buffalo 35
Guangzhou 35
Nuremberg 32
Milan 31
Phnom Penh 29
Vienna 29
Amman 28
Chicago 26
Dublin 26
London 26
Abidjan 24
Bridgetown 22
Nanchang 22
Bishkek 21
Hanoi 21
Libreville 21
Luanda 21
Panama City 21
Seoul 21
Tashkent 21
Dakar 20
Lappeenranta 20
Ulan Bator 19
Antananarivo 18
Dushanbe 18
Nassau 18
Niamey 18
Nouakchott 18
Podgorica 18
Riga 18
Bamako 17
Kigali 17
Paris 17
Pristina 17
Rome 17
Yerevan 17
Accra 16
Frankfurt am Main 16
Istanbul 16
Kinshasa 16
Reykjavik 16
Santa Cruz 16
Shenyang 16
Tallinn 16
Tripoli 16
Addis Ababa 15
Auckland 15
Baku 15
Cairo 15
Council Bluffs 15
Harare 15
Hebei 15
Willemstad 15
Managua 14
Ouagadougou 14
Boston 13
Conakry 13
Cotonou 13
Lusaka 13
Montevideo 13
Norwalk 13
Ogden 13
Port Moresby 13
San José 13
Warsaw 13
Windhoek 13
Aprilia 12
Athens 12
Totale 10.268
Salva come PNG Salva come JPEG
Nome #
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' 258
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection 236
Viral infections of the central nervous system in elderly patients: A retrospective study 226
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications 206
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. 202
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 200
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 198
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 194
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 193
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 182
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 180
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 178
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 175
Virological testing of cerebrospinal fluid in children aged less than 14 years with a suspected central nervous system infection: A retrospective study on 304 consecutive children from January 2012 to May 2015 169
Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection 156
Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data. 154
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 153
Legal scenarios in the coronavirus time: Medico legal implications in the aspects of governance 151
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: A 24-month longitudinal study 148
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities 147
Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a Patient: First Case in Europe 146
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. 142
Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. 142
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 141
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities. 139
Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period 137
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV. 137
Long-term therapy with nevirapine and tropism 135
HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection 134
Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ (Nature, (2020), 584, 7821, (425-429), 10.1038/s41586-020-2488-1) 133
Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital 132
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004–2012 in the Veneto Region, Italy 132
Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy. 131
Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. 131
Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection 131
Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients 128
Deep neck abscesses due to Acinetobacter baumanii infection. 124
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 124
Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019 124
Prevalence, molecular epidemiology and intra-hospital acquisition of Klebsiella pneumoniae strains producing carbapenemases in an Italian teaching hospital from January 2015 to September 2016. 123
Distribution of the CCR5 Delta 32 allele in Italian HIV type 1-infected and normal individuals 122
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 120
Infections in liver and lung transplant recipients: A national prospective cohort 120
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 120
Rational Diagnostic and therapeutic management of deep neck infections. Analysis of 233 consecutive cases 119
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 118
Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. 118
Drug-resistance mutations can be archived very early in HIV primary infection 118
Human immunodeficiency virus polymorphisms and zidovudine resistance 117
Association between cellular human immunodeficiency virus DNA level andimmunological parameters in patients with undetectable plasma viremia levelduring highly active antiretroviral therapy. 117
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients 116
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 116
Anti-HIV gene therapy strategies combining multiple siRNA with the entry inhibitor 116
Viral molecular testing of cerebrospinal fluid in adults with suspected central nervous system infection in an italian university hospital laboratory: A retrospective study on 1462 consecutive patients 116
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 115
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 115
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 114
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 113
Unboosted fosamprenavir is associated with low drug exposure in hiv-infected patients with mild-moderate liver impairment for hcv-related cirrhosis. 113
Detection of hepatitis C virus in an exhumed body identified the origin of a nosocomial transmission that caused multiple fatal diseases 113
Primary human herpesvirus 8 infection in immunocompetent children 111
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 111
Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals 110
HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection 110
Biological phenotype, replicative capacity and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 109
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 109
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 108
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors 108
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy 107
Switching of Inferred Tropism Caused by HIV during Interruption of Antiretroviral Therapy 105
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects 105
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 104
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS 103
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 103
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 103
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 103
Sustained Virological Response and Baseline Predictors in HIV-HCV Coinfected Patients Retreated with Pegylated Interferon and Ribavirin after Failing a Previous Interferon-Based Therapy: Systematic Review and Meta-Analysis 101
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 101
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 101
Le attività di sorveglianza di laboratorio delle infezioni batteriche invasive nella Regione Veneto (anno 2007) 100
Human immunodeficiency virus infection of human bone marrow stromal myoid cells 100
HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective. 98
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 97
Virological efficacy of abacavir: systematic review and meta-analysis 96
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 96
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load during different antiretroviral regimens. 94
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 94
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study 91
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy 91
miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals 90
Hbcab positivity is a risk factor for an increased detectability of hiv rna after switching to a two-drug regimen lamivudine-based (2dr-3tc-based) treatment: Analysis of a multicenter italian cohort 90
Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia 90
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 89
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 87
[Oculocutaneous albinism and tyrosinuria. Description of a clinical case]. 87
Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment 86
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells 86
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals 85
EFFICIENT AND REPRODUCIBLE NEW SEMIMICROMETHOD FOR THE DETECTION AND TITRATION OF HIV IN HUMAN PLASMA 85
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 85
Totale 12.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.398
article - articoli 56.537
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 264
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.174 0 0 0 139 73 110 72 164 212 95 187 122
2021/20221.699 45 155 158 88 63 70 71 150 202 76 228 393
2022/20231.255 304 136 65 123 201 129 5 86 140 10 45 11
2023/2024690 25 87 91 70 47 69 59 36 24 33 67 82
2024/20253.192 18 189 122 88 387 113 171 280 246 143 583 852
2025/20263.822 646 1.073 2.091 12 0 0 0 0 0 0 0 0
Totale 15.811